Alnylam Pharmaceuticals Inc <ALNY.O>: Truist Securities cuts target price to $315 from $410
ALNY•Related News
Rani Therapeutics names Michelle Gilson to board as audit committee chair
RANI•
Santander payments unit Getnet launches Engage loyalty platform for merchants
SAN•
UBS’s AML fail showcases two types of recidivist
UBS•
Faeth Therapeutics, Inc <FTH.O>: JonesTrading initiates coverage with buy rating; target price $55
FTH•
NRG Energy Q2 Net Income USD 506 Million
NRG•